YOQNEAM, Israel and SAN RAMON, California, March 21 /PRNewswire/ -- UltraShape Inc, a global leader in the body contouring market and the first to market a clinically proven, non-invasive body contouring system based on focused ultrasound technology, announced today that it has been selected as the Ultrasonic Industry Association's (UIA) New Product for 2007.

Entries for this competition were reviewed by a panel of members of the UIA Board of Directors. The entries were judged on several criteria, including unique product applications of ultrasound energy. This award will be presented on Wednesday, 21 March 2007 by UIA President Foster Stulen at the UIA Symposium, to be held at the National Physical Laboratory in Teddington, Middlesex, England.

"We are honored that the UltraShape CONTOUR I has been selected as the Ultrasonic Industry Association's New Product for 2007," said Rodger Stewart, President and Chief Executive Officer of UltraShape Inc. "It is recognition for a talented team of highly skilled professionals and scientists that has applied ultrasound know-how into developing the first ultrasound-based system for totally non-invasive body contouring; a treatment that places UltraShape at the cutting edge of body contouring and ultrasound technology."

Revolutionary technology

The UltraShape CONTOUR I system, based on patented focused ultrasound technology, is the first and only clinically proven -non-invasive body contouring solution for both men and women. It is designed to target and disrupt fat, leaving surrounding structures such as skin, blood vessels, and nerves intact. The UltraShape(TM) procedure is guided by proprietary real-time tracking and guidance software designed to deliver smooth, uniform body contouring results. The software guarantees adherence to a pre-determined treatment algorithm minimizing risk of contour irregularities, a common side effect of liposuction which is highly technique sensitive surgical procedure. The UltraShape(TM) procedure is performed during a convenient, "walk-in, walk-out" session carried out in an office-based environment; it requires no anesthesia or sedation, and the vast majority of patients report no pain or discomfort. After treatment, patients immediately resume their daily routines and there is no need for maintenance treatments.

The UltraShape CONTOUR I system is distributed throughout 45 countries worldwide. Over 20,000 commercial treatments have been performed to-date with high patient satisfaction.

About UltraShape

UltraShape Inc., founded in 2000, develops, manufactures and markets innovative, non-invasive solutions for the aesthetic medical field. The UltraShape expert team is dedicated to the development of cutting-edge body-contouring technology in a mission to enhance patients' self-image and sense of well-being.

The company was founded by Ami Glicksman M.D., a leading plastic surgeon in Israel, and Yoram Eshel, Ph.D, MBA, an expert in medical physics and high power ultrasound technology. UltraShape adheres to the highest scientific and quality standards and is ISO 13485: 2003 certified. The company has worldwide offices in the United States, Israel, France, United Kingdom, and Italy

For more information, please visit www.ultrashape.com.

About UIA

UIA is an international association for manufacturers, users, and researchers in ultrasonic technology whose mission is to improve processes, techniques and materials through the application of ultrasonic technology. For more information about the Ultrasonic Industry Association, go to www.ultrasonics.org or contact Fran Rickenbach, CAE, IOM, Executive Director at uia@ultrasonics.org or +1.937.586.3725

    
    For more information please contact:
    Abigail Marks, UltraShape
    abigail@ultrashape.com
    +972-4-909-9260
    
    Dariela Roffe, Porter Novelli
    dariela.roffe@porternovelli.co.uk
    +44-207-853-2234
    
    Amanda McNulty Sheldon, Fischer Health
    asheldon@fischerhealth.com
    +1-310-577-7870 x173

Source: UltraShape Inc